12:00 ETUSA Cell Therapy Manufacturing Market Highlights Lonza Group as Global Market Reaches USD 23.2 Billion by 2036 at 14.1% CAGR | Future Market Insightsprnewswire·22 hours agoLZAGY+1.50%
Lonza H1 Results Climb, Lifts FY26 CORE EBITDA Margin View, Backs Sales Growth Forecastrttnews·Jul 22 at 12:15 AMLZAGY+1.50%
LONN: Sales and margins surged, outlook raised, and a major business divestment was completedQuartr·Jul 22 at 12:02 AMLZAGY+1.50%
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AGUnusual Whales·Jul 8 at 10:58 AMAVTR+3.66%LZAGY+1.50%
Lonza: Q1 Performance In Line With Expectations; Confirms 2026 Outlooknasdaq·May 8 at 01:00 AMO6Z0.00%LZAGY+1.50%
Lonza Says Big Pharma Might Delay Outsourcing Decisions Amid U.S. InvestmentsMorningStar·May 8 at 12:20 AMLZAGY+1.50%IBB+0.82%
Assessing Lonza Group’s Valuation As FDA AI Collaboration Puts Its Drug Development Capabilities In FocusSimplywall·Apr 28 at 01:02 PMO6Z0.00%LZAGY+1.50%
RBC Capital Reaffirms Their Buy Rating on Lonza Group Ltd (LONN)Tip Ranks·Apr 24 at 01:55 AMLZAGY+1.50%
